Home > Dermatology > SPIN 2022 > IMIDs in Adults and Children: New Developments > Conceptual framework of adverse drug reactions may improve treatment of patients with IMIDs

Conceptual framework of adverse drug reactions may improve treatment of patients with IMIDs

Presented By
Ms Jette van Lint , Pharmacovigilance Centre Lareb, the Netherlands
Conference
SPIN 2022
Doi
https://doi.org/10.55788/b8c05348
A conceptual framework may offer practical solutions when dealing with adverse drug reactions (ADRs) in immune-mediated inflammatory diseases (IMIDs). Researchers identified 6 main themes, which influence the timecourse of ADRs.     Many patients with IMIDs suffer from ADRs during chronic drug treatment. Usually, only ADRs that occur with drug use are reported. However, the Dutch pharmacist and researcher Ms Jette van Lint (Pharmacovigilance Centre Lareb, the Netherlands) proposed that the patient-reported medical information on the common patterns in the course and timeframe of ADRs, which are often overlooked, may provide valuable further insights for finding practical solutions when dealing with ADRs in patients with IMIDs [1]. Ms van Lint and her team used qualitative data from the Dutch Biologic Monitor (DBM) to assess the patient’s descriptions of the course of ADRs they experienced. Of consecutive patients using biologics mainly for IMIDs, 53...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on